Clinical trials of treatment for noncognitive symptoms of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

被引：0
|
作者：
Homma, A
Brodaty, H
Bruno, G
Cummings, JL
Gilman, S
Gracon, S
McKeith, IG
机构：
[1] PRINCE HENRY HOSP,ACAD DEPT PSYCHOGERIATR,LITTLE BAY,NSW 2036,AUSTRALIA
[2] UNIV ROMA LA SAPIENZA,DEPT NEUROL SCI,I-00185 ROME,ITALY
[3] UNIV CALIF LOS ANGELES,DEPT NEUROL,LOS ANGELES,CA 90024
[4] WARNER LAMBERT PARKE DAVIS,ANN ARBOR,MI 48105
[5] NEWCASTLE GEN HOSP,INST HLTH ELDERLY,DEPT OLD AGE PSYCHIAT,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
来源：
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 1997年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [21] Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group
    Blake, P
    Evans, JG
    Fallowfield, L
    Fentiman, I
    Gosney, M
    Grundy, E
    Harper, P
    Heath, H
    Heath, I
    Khaw, KT
    Northover, J
    Oliver, G
    Speechley, V
    Twentyman, P
    Whelan, J
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 1 - 3
  • [22] Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group
    British Journal of Cancer, 2000, 82 (1) : 1 - 3
  • [23] Adequacy of Using Consensus Guidelines for Diagnosis of Dementia with Lewy Bodies in Clinical Trials for Drug Development
    Ikeda, Manabu
    Mori, Etsuro
    Iseki, Eizo
    Katayama, Sadao
    Higashi, Yasuto
    Hashimoto, Mamoru
    Miyagishi, Hideaki
    Nakagawa, Masaki
    Kosaka, Kenji
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2016, 41 (1-2) : 55 - 67
  • [24] Treatment of vascular dementia -: evidence from clinical trials with cholinesterase inhibitors
    Erkinjuntti, T
    Román, G
    Gauthier, S
    NEUROLOGICAL RESEARCH, 2004, 26 (05) : 603 - 605
  • [25] Treatment of vascular dementia -: evidence from clinical trials with cholinesterase inhibitors
    Erkinjuntti, T
    Román, G
    Gauthier, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 226 (1-2) : 63 - 66
  • [26] A treatment of vascular dementia: Evidence from clinical trials with cholinesterase inhibitors
    Erkinjuntti, T
    NEUROBIOLOGY OF AGING, 2004, 25 : S8 - S8
  • [27] New findings from clinical trials in Europe and the United States: Aripiprazole for the treatment of psychiatric symptoms associated with dementia
    Streim, JE
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 377 - 377
  • [28] Dementia drug treatment in clinical practice: data on 7570 patients from SveDem, the Swedish Dementia Registry
    Religa, D.
    Johnell, K.
    Eriksdotter, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 94 - 94
  • [29] BIOMARKERS OF SARCOPENIA IN CLINICAL TRIALS RECOMMENDATIONS FROM THE INTERNATIONAL WORKING GROUP ON SARCOPENIA
    Cesari, M.
    Fielding, R. A.
    Pahor, M.
    Goodpaster, B.
    Hellerstein, M.
    Van Kan, G. Abellan
    Anker, S. D.
    Rutkove, S.
    Vrijbloed, J. W.
    Isaac, M.
    Rolland, Y.
    M'Rini, C.
    Aubertin-Leheudre, M.
    Cedarbaum, J. M.
    Zamboni, M.
    Sieber, C. C.
    Laurent, D.
    Evans, W. J.
    Roubenoff, R.
    Morley, J. E.
    Vellas, B.
    JOURNAL OF FRAILTY & AGING, 2012, 1 (03): : 103 - 111
  • [30] STATISTICAL CONCEPTS IN THE PLANNING AND EVALUATION OF DRUG SAFETY FROM CLINICAL-TRIALS IN DRUG DEVELOPMENT - ISSUES OF INTERNATIONAL HARMONIZATION
    ONEILL, RT
    STATISTICS IN MEDICINE, 1995, 14 (9-10) : 1117 - 1127
12345